The carbon footprint of respiratory treatments in Europe and Canada: an observational study from the CARBON programme

Relievers account for the majority of inhaler use and associated GHG emissions. Implementing treatment guidelines can reduce the unmet need in respiratory care by improving disease control and reducing reliever overuse and the overall carbon footprint. https://bit.ly/3zh3c2B

Detalles Bibliográficos
Autores principales: Janson, Christer, Maslova, Ekaterina, Wilkinson, Alexander, Penz, Erika, Papi, Alberto, Budgen, Nigel, Vogelmeier, Claus F., Kupczyk, Maciej, Bell, John, Menzies-Gow, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Agora
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363844/
https://www.ncbi.nlm.nih.gov/pubmed/35777767
http://dx.doi.org/10.1183/13993003.02760-2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363844/
https://www.ncbi.nlm.nih.gov/pubmed/35777767
http://dx.doi.org/10.1183/13993003.02760-2021

Ejemplares similares